⛔ This position is no longer available.
University: University Medical Center Groningen
Country: Netherlands
Deadline: 2026-04-01
Fields: Biomedical Sciences, Molecular Biology, Immunology, Oncology, Bioinformatics
Topic: Netherlands – Fully Funded PhD in Cancer Research at University Medical Center Groningen
Fields: Biomedical Sciences, Molecular Biology, Immunology, Oncology, Bioinformatics
Position: PhD
Country: europe
Deadline: 2026-04-01
University: University Medical Center Groningen
Real Country: Netherlands
Main Category: life & medical sciences
—
Are you passionate about advancing cancer treatment through innovative research in molecular oncology and immunotherapy? Do you aspire to contribute to the next generation of breakthroughs in cancer care, working at the intersection of cutting-edge science and clinical application? If your career goals include making a real impact on cancer patient outcomes while developing advanced research skills in a collaborative, international setting, this unique PhD opportunity in the Netherlands may be the perfect next step.
About the University or Research Institute
The University Medical Center Groningen (UMCG) stands as one of the Netherlands’ premier academic medical institutions. Located in the vibrant city of Groningen, UMCG is renowned for its world-class research, education, and patient care. As a leading center for biomedical innovation, UMCG is deeply committed to translating scientific discoveries into improved clinical outcomes. The center is also a key partner in the IMMUNO-PROT consortium, a national collaboration funded by the Dutch Cancer Society (KWF), which unites expertise from top Dutch universities and medical centers, including Maastricht University, Radboudumc, and Erasmus MC. This collaborative environment provides PhD candidates with access to state-of-the-art facilities, interdisciplinary expertise, and a stimulating academic culture.
The Netherlands itself is recognized globally for its outstanding higher education system, high living standards, and rich cultural heritage. International students benefit from a welcoming atmosphere, a strong focus on research and innovation, and a high quality of life, making it an ideal destination for ambitious researchers.
Research Topic and Significance
The IMMUNO-PROT consortium’s research focuses on molecular and immune radiation oncology, specifically targeting the optimization of proton therapy-immunotherapy combination strategies for head-and-neck cancer. This area of research is of critical importance in today’s medical landscape, as head-and-neck cancers remain challenging to treat, with significant impacts on patient quality of life.
Proton therapy represents a major advancement in radiation oncology, offering precise targeting of tumors while sparing healthy tissue. When combined with immunotherapy—which harnesses the body’s own immune system to fight cancer—there is potential to achieve more effective and durable responses. However, the scientific mechanisms underlying these combined effects remain incompletely understood. This project aims to elucidate how proton therapy can enhance immunotherapy efficacy by triggering specific immune responses, while preserving systemic immune competence. The insights gained will not only inform clinical practice but may also lead to the development of novel therapeutic strategies for cancer patients worldwide.
Project Details
The IMMUNO-PROT consortium is offering five fully funded PhD positions, each embedded within a specific work package and hosted by leading Dutch research institutions:
– WP1: Proton therapy-induced cell-intrinsic inflammatory signalling
– PhD1 (UMCG, Groningen): Investigate molecular mechanisms of DNA repair, cell cycle control, and inflammatory signaling triggered by proton therapy.
– PhD2 (Maastricht University, Maastricht): Identify mediators of proton-induced inflammatory responses and define biomarkers for guiding therapy combinations.
– WP2: Immune impact and combined responses of proton therapy with immunomodulatory agents
– PhD3 (Radboudumc, Nijmegen): Examine how proton therapy and immunomodulatory agents affect immune cell function and tumor-immune cell interactions using advanced co-culture models.
– WP3: Optimal proton therapy and immunotherapy in vivo combination strategies
– PhD4 (Erasmus MC, Rotterdam): Study immune-tumor cell interactions and immunomodulatory effects of proton therapy in ex vivo and in vivo models.
– PhD5 (UMCG, Groningen): Validate novel immunomodulatory targets using patient-derived tumoroids, organoids, and in vivo models, including FLASH proton therapy.
Supervision is provided by an accomplished team of principal investigators at each institution, ensuring high-quality mentorship and exposure to a wide range of experimental techniques, including omics platforms, mechanistic modeling, molecular biology, and advanced radiation technologies.
Candidate Profile
Ideal candidates for these PhD positions will possess:
– A Master’s degree in a relevant biomedical field, qualifying for PhD enrollment at the hosting institution.
– Experience in molecular cell biology, radiation biology, immunology, and/or bioinformatics.
– A strong motivation for experimental, laboratory-based oncology research.
– Excellent communication skills and the ability to work effectively in a multidisciplinary team.
– An affinity with head-and-neck cancer research is considered an advantage.
– Students who are in the process of completing their Master’s degree during the application period are also encouraged to apply.
A proactive, collaborative mindset and a passion for scientific discovery are essential for success in this dynamic research environment.
Application Process
The application deadline for these positions is 2026-04-01. Interested candidates should refer to the official advertisement for detailed application instructions and further information on the available projects:
Reference link:
https://werkenbijumcg.nl/-/vacatures/phd-position-in-cancer-research/10419-02s000a96p
Conclusion
This is a rare opportunity to join a leading research consortium at the forefront of cancer research, supported by top Dutch medical centers and universities. Successful candidates will receive comprehensive training, access to advanced research facilities, and the chance to contribute to transformative advances in cancer therapy. If you are driven to make a difference in the fight against cancer and seek a stimulating, collaborative academic environment, you are strongly encouraged to apply. For more opportunities in biomedical research, continue to follow similar announcements and stay informed about future openings.
Questions & Answers
Question: What makes the Netherlands an attractive destination for international PhD students in biomedical sciences?
The Netherlands offers a high standard of living, a strong international research reputation, and a collaborative academic culture. English is widely spoken, and universities provide excellent support for international students, making it an ideal environment for advanced study.
Question: What is proton therapy, and why is it important in cancer treatment?
Proton therapy is a form of radiation treatment that uses protons instead of X-rays to target tumors with high precision, reducing damage to surrounding healthy tissues. It is especially valuable for treating cancers in sensitive areas, such as the head and neck.
Question: Can I apply if I have not yet completed my Master’s degree?
Yes, students who are in the process of completing their Master’s degree during the application period are welcome to apply, provided they will qualify for PhD enrollment at the hosting institution.
Question: What types of research training and development opportunities are available?
PhD candidates will benefit from interdisciplinary training, opportunities to attend national and international conferences, and access to state-of-the-art research facilities within the IMMUNO-PROT consortium.
Question: Are these PhD positions fully funded?
Yes, all five PhD positions are fully funded, providing a competitive salary and support for research and training activities.
Question: What are the main research skills I can expect to develop?
Candidates will gain expertise in molecular biology, immunology, radiation biology, advanced cell culture, omics technologies, and mechanistic modeling, as well as collaborative research and scientific communication skills.
Question: How do I find more information or apply for these positions?
Detailed information and application instructions are available at the official UMCG job portal:
https://werkenbijumcg.nl/-/vacatures/phd-position-in-cancer-research/10419-02s000a96p
Question: What is the preferred start date for these PhD positions?
The preferred start date is July 1, 2026, but there is flexibility depending on the candidate’s circumstances.
—
Want to calculate your PhD admission chances? Try it here:
https://phdfinder.com/2026/03/12/phd-admission-chance-calculator/
We’re an independent team helping students find opportunities.
Found this opportunity helpful? Support us with a coffee!
